The success of the Human Genome Project has catalyzed an amazing explosion of molecular insight into the causes of human disease. However, identifying the genes implicated in disease is just the first step on the long road to understanding the biology of the anomaly and to designing successful therapeutic intervention. Although human populations provide a superb source of carefully described, diverse mutations that can tell us much about normal and abnormal gene function, biological experimentation in humans is very difficult. Model systems from yeast to mouse are therefore contributing widely to our understanding of disease mechanisms and pointing the way to rational therapies.
It is becoming increasingly clear that there is at least some genetic contribution to most human disease. However, even where it does not play a part in disease aetiology, genetics can be used to unravel biochemistry and physiology. By perturbing normal pathways at discrete points, gene mutations provide excellent tools for dissecting biochemical and developmental pathways and molecular interactions in many different organisms. A major insight to emerge from the various genome projects ( 2) . The major components, although duplicated and somewhat diverged, are nevertheless highly conserved through evolution to higher eukaryotes (3, 4) . Dividing human cells clearly have to achieve the same faultless standards of cell-cycle control, so that each tissue and organ grows to optimal size and then stops, apart from making necessary replacements where there is continuous cell-turnover (for example, in the gut, liver, or bone marrow). Loss of growth control, through mutation or viral invasion, leads either to cell death or to uncontrolled proliferationdegenerative disease or cancer.
Many of the genes identified in yeast that are required for tight cell-cycle control, including cyclins, cyclin-dependent kinases (CDKs), and inhibitors of CDKs (1,2), have close homologues with very similar function in mammalian cells, and mutations in a number of these have been implicated in cancer (4) . In the past couple of years, allele-loss studies in melanomas and a number of other tumors have led to the identification of the human cyclin dependent kinase inhibitor p16 as a gene whose loss of function, possibly in conjunction with its closely linked relative p15, is involved in many different cancers. Rare germ-line mutations in p16 (CDKN2) have been observed in families with a strong predisposition to melanoma (4). The pre-existing studies conducted in yeast immediately helped to illuminate the mechanisms of human disease when the involvement of p16 and p15 was determined by positional cloning efforts.
DNA sequence proof-reading and repair are also strongly conserved from bacteria, through yeast, to human. A number of genes mutated in families with hereditary nonpolyposis colon cancer (HNPCC) (5) were defined partly through the discovery that these tumors carry a high frequency of de novo mutations in simple repeat sequences, which are usually used as polymorphic genetic markers. One of the groups who identified some of the genes involved in these human tumors did so through knowledge of the genes involved in DNA repair in bacteria and yeast (6) .
Different types of DNA damage are repaired by different nucleotide excision-repair enzymes. A failure to repair UV-dependent damage is the underlying cause of the various genetic forms of xeroderma pigmentosum (XP), and in each type (complementation group) of XP elucidated so far, a distinct gene from this pathway has been found to be mutated (7, 8) . In most cases functional analysis was greatly helped by the fact that most of the genes were already well studied in yeast as yeast radiation-sensitivity (RAD) genes.
The human gene mutated in ataxia telangiectasia (ATM) was recently identified through positional cloning (9) . ATM shows strong sequence homology to the yeast TELl and MEC1 genes, mutations which also confer increased sensitivity to DNA damage (10) . The implied functional conservation suggests that appropriate mutants in yeast and other eukaryotes may be useful for understanding the disease mechanism and for suggesting approaches to therapy in ataxia telangiectasia.
The whole of the S. cerevisiae genome has been sequenced and is publicly available for sequence comparisons (1 ) . Whenever an interesting gene is isolated in another species, yeast homologies can be identified and vice versa (12) . If there is a yeast gene, but mutants are not available, they can readily be created in the hope that this will help in suggesting and exploring function in an experimentally amenable organism.
CAENORHABDITIS ELEGANS:
A SIMPLE DEVELOPMENTAL MODEL AND GENOME PROJECT PROTOTYPE This insignificant-looking, soil-dwelling nematode worm was recognized by Sidney Brenner in the mid-1960s as the ideal model system for studying development in close conjunction with genetics. The adult organism consists of just about 1,000 cells. The exact developmental derivation of each has been painstakingly elucidated (1 3). Developmental and behavioral mutants have been derived and mapped and many of the genes identified. The whole of the -100-kb genome has been isolated in overlapping genomic clones, about 50% of which have now been sequenced in the original prototypic genome project (14) . A surprising number of major principles in development have been shown to be conserved across the phyla from C. elegans to human. For example, although the concept of apoptosis was first noted in human tissue by clinically trained pathologists (15) , the study of cell fate mutants in C. elegans has contributed enormously to elucidation of conserved genes involved in developmentally regulated and pathologically programmed cell death (16, 17) .
In another key area, the simplicity of the nematode neural system has permitted dissection of axon guidance mechanisms. The possibility of ready mutant selection and gene identification at affected loci has led to pathways defined by the uncoordinated series (unc genes). Most of the molecules involved turn out to be highly conserved in both sequence and function (18 (22) . However, recently, mild limb developmental phenotypes have been ascribed to heterozygous mutation in human HOXD13 (23) and mouse Hoxal3 (24) , showing synpolydactyly and hypodactyly, respectively.
The eye is perhaps a more readily recognized functional unit than the anteroposterior axis. Surprisingly, since insect and vertebrate eyes are so different and have probably evolved independently (25) , eye development has provided most important information on evolutionarily con-served mechanisms. Ironically, one of the earliest (most upstream) of transcriptional regulators controlling eye development, the PAX6 gene, was first defined in human and in mouse as the gene mutated in aniridia (absence of the iris) and in Small eye, respectively (26, 27) . Subsequently, it was discovered that a Drosophila homologue exists, maps to the eyeless locus, and is functionally disrupted by transposon insertion in eyeless flies (28) . Even more astonishingly, carefully controlled ectopic expression of either the fly gene or the mouse homologue in different Drosophila imaginal disks leads to the development of more or less normal eyes in ectopic sites such as on leg, wing, or antennae (29) . This amazing conservation of function (and sequence) was a major spur to the reaffirmation of the concept of wide-ranging evolutionary gene conservation (30) .
This idea is not new, but has been critical in the elucidation of many complexities in Ras and tyrosine kinase signaling pathways through the analysis of Drosophila eye mutants (31, 32) . Insight into these pathways is important since they control aspects of human developmental regulation, hormone action, and cancer. Most recently, another type of signaling molecule, a homologue of the Drosophila segment polarity gene hedgehog, which is implicated as a gradient morphogen, was shown to be critical in human mid-line head development. Loss of one copy of the human sonic hedgehog (SHH) gene can lead to holoprosencephaly, HPE3 (3 3,34 39 and 40; also see the December 1996 issue of Development). The scene is now set to identify the mutant genes responsible for the new abnormal phenotypes. The genome revolution means that this will be possible in an organism which before this had very little genetics (40) .
MOUSE MUTANTS BY SELECTION AND MANIPULATION
Despite the experimental usefulness of "lower" organisms, there remain endless reasons to continue using the laboratory mouse as the ideal model system for human disease. There are many cases where it is essential to use a mammalian system to understand the fine detail of developmental or metabolic pathways implicated in human disease. It is important to approximate as closely as possible the human physiological parameters in developing models where the aim is to elucidate and eventually treat human diseases. Many mouse mutants have been collected and genetically analyzed over the last five or six decades (41) . Perhaps one good recent illustration of the usefulness of mouse models in unraveling developmental and metabolic control is our recently improved insight into obesity, appetite control, and energy metabolism, where positional cloning in mouse mutants has helped to uncover completely new pathways of gene interaction (42, 43) . There is no doubt that the biotechnology industry considers this growth area well worth investing in.
For about the past 10 years it has also been possible to manipulate mouse embryos by insertion of special, totipotent embryonic stem (ES) cells at the blastocyst stage. These cells can contribute to the animal that is eventually born and in most cases the ES cell contribution will be propagated through the germline, so that breeding to homozygosity is possible. Over 
HUMANS AS THE ULTIMATE MODEL
There is no richer source of mutations than humankind, since so many variants and anomalies, from mild to severe ones, arise in our mainly outbred populations; these are carefully described, analyzed, and nurtured, and can be immortalized as permanent cell lines for long-term study at the DNA level. Improved genetic and physical mapping techniques have made possible increasingly rapid gene identification. Conserved synteny and gene order associations allow quick recognition of homologous human and mouse mutations, as in the case of aniridia and Small eye. There is much two-way traffic between different model systems, allowing the unraveling of complex interactive pathways. It is becoming increasingly clear that these pathways are generally highly conserved, so that analysis in one system can be extrapolated to another with sufficient confidence, at least to suggest novel experiments to check out the expected homology. Many human conditions give new insight into basic biology, as in the case of patched and hedgehog. Complex physiological pathways may also be illuminated in this way; for example, we have learned a great deal about ion channels from a wide spectrum of different diseases caused by mutations in these genes (45) . This knowledge should lead to the development of some very finely tuned and specific drugs to ameliorate the conditions caused by these mutations.
MODIFIERS REVEAL INTERACTING GENES
Several of the organisms discussed here have excellent genetics, which can be used to search for modifier loci by looking for variants that alter the phenotype of a specified gene. These variants can be naturally occurring as in humans, or induced by mutagenesis in the model systems. In human populations the concept of interacting gene variants forms the basis of searches for multifactorial disease loci. Large-scale genetic analysis in selected populations or in affected sib pairs is required to track down and identify gene loci that travel with the disease phenotype (46) . In yeast and Drosophila, the mutagenesis approach has been used very effectively to define genes in the same pathway. This is elegantly illustrated by the definition of signaling cascades required for Drosophila eye development (47) . Large-scale mouse mutagenesis experiments are planned to search for new phenotypes for old diseases such as deafness and neurodegeneration (48) . The genes involved will often be members of the same pathway.
Moving into the next millennium toward the end of the first phase of the genome projects, we are seeing an exciting era of biological consolidation and a much deeper understanding of the apparently universal underlying principles which govern the complex interactions required to support life across many phyla. Properly used, this knowledge should help to conserve and improve all aspects of life on earth.
